Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2021-04-20 | "She holds a B.Sc. in pharmacology from Kings College, University of London." |
| 2022-04-25 | "Ms. Lawton is an executive leader with more than 30 years experience in biopharma... She holds a B.Sc. in pharmacology from Kings College, University of London." |
| 2023-04-25 | "She holds a B.Sc. in pharmacology from Kings College, University of London." |
| 2024-04-29 | "Ms. Lawton is an executive leader with more than 35 years of experience in biopharma..." |
| 2025-03-24 | Alison Lawton (12) Consists of 51,667 shares of common stock and 12,854 shares of common stock underlying options... |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-07-06